3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
3
Polycystic Ovary Syndrome
2
Obesity
2
Neoplasms
2
Motor Activity
2
Feeding Behavior
2
Cardiovascular Diseases
2
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Overweight
1
Neuroendocrine Tumors
1
Myocardial Infarction
1
Myeloproliferative Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Intermittent Fasting
1
Inflammation
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Diabetes Mellitus
1
Cognitive Dysfunction
1
Angina, Unstable
1
Interventions
fludarabine phosphate
20
Peripheral Blood Stem Cell Transplantation
20
Cyclophosphamide
17
Busulfan
16
ruxolitinib
14
Tacrolimus
12
Whole-Body Irradiation
9
Mycophenolic Acid
9
Methotrexate
8
Antilymphocyte Serum
8
Cyclosporine
7
peginterferon alfa-2a
6
Hydroxyurea
6
Filgrastim
6
Etoposide
6
Aspirin
6
fludarabine
5
Prednisone
5
Melphalan
5
Imatinib Mesylate
5
Cytarabine
5
Decitabine
4
pomalidomide
3
givinostat hydrochloride
3
givinostat
3
Topotecan
3
Thiotepa
3
Radiotherapy
3
Lenalidomide
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Polycythemia Vera
×
Diet, Mediterranean
×
Clear all
NCT03907436
2020-03-24
NUTRIENT
University of California, Irvine
Phase NA
Completed
30 enrolled